(RDY) Dr. Reddy’s - Performance 2.4% in 12m
Compare RDY with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
33.77%
#36 in Group
Rel. Strength
49.74%
#4015 in Universe
Total Return 12m
2.37%
#58 in Group
Total Return 5y
59.34%
#29 in Group
P/E 17.6
39th Percentile in Group
P/E Forward 15.3
56th Percentile in Group
PEG 4.51
91th Percentile in Group
FCF Yield 0.70%
42th Percentile in Group
12m Total Return: RDY (2.4%) vs XLV (-0.5%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
10.2% | 175% | 405% | 55.8 | 41 | 0.61 | 61.4% | 10.7% |
LLY NYSE Eli Lilly |
2.12% | 13.3% | 466% | 62.7 | 31.5 | 1.05 | 40.3% | 34.5% |
NVS NYSE Novartis |
-1.21% | 24.1% | 59.8% | 18 | 12.9 | 1.23 | 36.2% | 11% |
SFZN SW Siegfried Holding |
-2.09% | 1.78% | 95.3% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
SUPN NASDAQ Supernus Pharmaceuticals |
-4.71% | 6.55% | 74.3% | 24 | 20.2 | 1.47 | -20.8% | -17% |
SOBI ST Swedish Orphan Biovitrum |
-8.43% | 1.39% | 42.8% | 23.3 | 18.7 | 1.44 | 11.8% | 14.7% |
SAN PA Sanofi |
-15.7% | 10.9% | 24.2% | 21.9 | 11.6 | 0.93 | -22.1% | -24.8% |
NOVN SW Novartis |
-7.92% | 11.1% | 33.1% | 17.9 | 12.8 | 1.22 | 36.2% | 11.2% |
Performance Comparison: RDY vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for RDY
Total Return (including Dividends) | RDY | XLV | S&P 500 |
---|---|---|---|
1 Month | 2.47% | -7.37% | -5.89% |
3 Months | -7.64% | -4.55% | -12.45% |
12 Months | 2.37% | -0.54% | 6.72% |
5 Years | 59.34% | 46.59% | 101.06% |
Trend Score (consistency of price movement) | RDY | XLV | S&P 500 |
1 Month | -29.4% | -82.6% | -74.5% |
3 Months | -62.6% | -37.8% | -88.2% |
12 Months | -19.3% | -1.6% | 66.1% |
5 Years | 62.3% | 90.1% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #26 | 10.6% | 8.88% |
3 Month | #68 | -3.23% | 5.49% |
12 Month | #58 | 2.93% | -4.08% |
5 Years | #28 | 8.70% | -20.8% |
FAQs
Does RDY Dr. Reddy’s outperforms the market?
Yes,
over the last 12 months RDY made 2.37%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.54%.
Over the last 3 months RDY made -7.64%, while XLV made -4.55%.
Over the last 3 months RDY made -7.64%, while XLV made -4.55%.
Performance Comparison RDY vs Indeces and Sectors
RDY vs. Indices RDY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 4.81% | 8.36% | -4.83% | -4.35% |
US NASDAQ 100 | QQQ | 5.67% | 8.75% | -4.30% | -3.16% |
US Dow Jones Industrial 30 | DIA | 5.98% | 8.29% | -5.37% | -2.94% |
German DAX 40 | DAX | -0.55% | 11.9% | -21.9% | -15.8% |
Shanghai Shenzhen CSI 300 | CSI 300 | 4.10% | 9.97% | -7.11% | -3.52% |
Hongkong Hang Seng | HSI | 0.52% | 12.3% | -6.35% | -13.9% |
India NIFTY 50 | INDA | 0.44% | -2.30% | -7.28% | -0.70% |
Brasil Bovespa | EWZ | 1.25% | 7.55% | -7.78% | 11.8% |
RDY vs. Sectors RDY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 4.56% | 8.13% | -13.6% | -11.2% |
Consumer Discretionary | XLY | 5.68% | 6.39% | -7.57% | -6.85% |
Consumer Staples | XLP | 1.51% | -0.73% | -15.1% | -11.6% |
Energy | XLE | 0.09% | 12.6% | -5.89% | 12.7% |
Financial | XLF | 3.44% | 6.98% | -13.0% | -16.6% |
Health Care | XLV | 4.41% | 9.84% | -3.43% | 2.91% |
Industrial | XLI | 3.69% | 7.17% | -4.91% | -2.99% |
Materials | XLB | 3.09% | 9.12% | 2.25% | 9.91% |
Real Estate | XLRE | -0.53% | 5.36% | -6.18% | -14.7% |
Technology | XLK | 6.17% | 11.4% | 1.98% | 3.58% |
Utilities | XLU | 1.50% | 2.89% | -10.6% | -22.0% |
Aerospace & Defense | XAR | 3.12% | 2.43% | -14.6% | -21.8% |
Biotech | XBI | 1.25% | 14.4% | 9.72% | 11.3% |
Homebuilder | XHB | 3.86% | 9.31% | 13.1% | 11.5% |
Retail | XRT | 3.11% | 4.58% | -0.16% | 6.76% |